Sitagliptin drug class
Pro Research Analysisby 
Searched over 200M research papers
Sitagliptin Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
DPP-4 Inhibitors as Antidiabetic Agents
Sitagliptin belongs to the drug class known as dipeptidyl peptidase-4 (DPP-4) inhibitors, often referred to as "gliptins" 1456+2 MORE. This class of medications is widely used for the treatment of type 2 diabetes mellitus due to their ability to improve blood sugar control with a low risk of causing hypoglycemia and generally good tolerability 1359.
Mechanism of Action of DPP-4 Inhibitors
DPP-4 inhibitors like sitagliptin work by blocking the DPP-4 enzyme, which leads to increased levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) 156. These hormones help stimulate insulin release and decrease glucagon secretion in a glucose-dependent manner, improving blood glucose regulation in people with type 2 diabetes 135.
Clinical Use and Safety Profile
Sitagliptin is approved for use as monotherapy or in combination with other antihyperglycemic drugs, including metformin and sulfonylureas, for adults with type 2 diabetes 1359. It is generally well tolerated, with a low risk of hypoglycemia and a neutral effect on body weight 359. Clinical studies have shown that sitagliptin is effective in reducing glycosylated hemoglobin (HbA1c) and fasting plasma glucose levels 359. Concerns about pancreatitis and pancreatic cancer have not been supported by causal evidence to date 39.
Additional Properties and Research
Beyond its primary use in diabetes, sitagliptin has been studied for potential benefits in other conditions, such as neuroprotection and anti-inflammatory effects, including possible roles in Alzheimer's disease and brain injury models 16710. However, its main and well-established use remains as a DPP-4 inhibitor for type 2 diabetes management 1359.
Conclusion
Sitagliptin is a member of the DPP-4 inhibitor drug class, a group of antidiabetic medications that improve blood sugar control in type 2 diabetes by enhancing incretin hormone activity. It is well tolerated, effective, and widely used as part of diabetes management, either alone or in combination with other drugs 1359.
Sources and full results
Most relevant research papers on this topic